Vertex Pharmaceuticals (VRTX) Non-Current Deffered Revenue (2009 - 2017)
Vertex Pharmaceuticals (VRTX) posted Non-Current Deffered Revenue of $1.7 million for Q4 2017, down 40.83% on a QoQ basis from $2.9 million in Q3 2017, and down 73.97% year-over-year from $6.6 million in Q4 2016.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Non-Current Deffered Revenue (2009 - 2017) Analysis & Trends
Vertex Pharmaceuticals has reported Non-Current Deffered Revenue for 9 years, with the latest figure at $1.7 million in Q4 2017.
- On a quarterly basis, Non-Current Deffered Revenue fell 73.97% year-over-year to $1.7 million in Q4 2017; TTM through Dec 2017 was $1.7 million, a 73.97% decrease from a year earlier, with the FY2017 full-year figure at $1.7 million, down 73.97% from the prior year.
- Non-Current Deffered Revenue was $1.7 million for Q4 2017 at Vertex Pharmaceuticals, down from $2.9 million in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $90.3 million in Q1 2013, with the low at $1.7 million in Q4 2017.
- Average Non-Current Deffered Revenue over 5 years is $28.1 million, with a median of $19.3 million recorded in 2015.
- The sharpest annual moves came in 2013 and 2017: Non-Current Deffered Revenue dropped 22.28% in 2013, then sank 73.97% in 2017.
- Over 5 years, Non-Current Deffered Revenue stood at $49.5 million in 2013, then plunged by 43.78% to $27.8 million in 2014, then tumbled by 65.07% to $9.7 million in 2015, then slumped by 31.73% to $6.6 million in 2016, then sank by 73.97% to $1.7 million in 2017.
- The last three Non-Current Deffered Revenue figures came in at $1.7 million (Q4 2017), $2.9 million (Q3 2017), and $4.2 million (Q2 2017), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | - |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | - |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | - |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | - |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | - |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 1.73 Mn |
| Sep 30, 2017 | 2.92 Mn |
| Jun 30, 2017 | 4.16 Mn |
| Mar 31, 2017 | 5.74 Mn |
| Dec 31, 2016 | 6.63 Mn |
| Sep 30, 2016 | 6.56 Mn |
| Jun 30, 2016 | 7.41 Mn |
| Mar 31, 2016 | 8.49 Mn |
| Dec 31, 2015 | 9.71 Mn |
| Sep 30, 2015 | 17.50 Mn |
| Jun 30, 2015 | 21.02 Mn |
| Mar 31, 2015 | 24.00 Mn |
| Dec 31, 2014 | 27.81 Mn |
| Sep 30, 2014 | 34.72 Mn |
| Jun 30, 2014 | 38.11 Mn |
| Mar 31, 2014 | 43.89 Mn |
| Dec 31, 2013 | 49.46 Mn |
| Sep 30, 2013 | 77.35 Mn |
| Jun 30, 2013 | 84.07 Mn |
| Mar 31, 2013 | 90.30 Mn |
API Access
Vertex Pharmaceuticals Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();